Equities

K Pharma Inc

4896:TYO

K Pharma Inc

Actions
  • Price (JPY)741.00
  • Today's Change-3.00 / -0.40%
  • Shares traded6.10k
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024 06:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3,2661,337189
Total Receivables, Net------
Total Inventory11109.88
Prepaid expenses31226.02
Other current assets, total0.391.480.00
Total current assets3,3091,371205
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets4.933.641.08
Total assets3,3141,375206
LIABILITIES
Accounts payable12102.58
Accrued expenses302218
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total1372.092.97
Total current liabilities1783423
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total314.623.50
Total liabilities2093827
SHAREHOLDERS EQUITY
Common stock854100100
Additional paid-in capital3,0032,249699
Retained earnings (accumulated deficit)(753)(1013)(621)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--0.00--
Total equity3,1051,336179
Total liabilities & shareholders' equity3,3141,375206
Total common shares outstanding121212
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.